Sangamo Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.15

+0.00 (+3.26%)

As of Oct 3, 2:26 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +13,806.8% upside

Low Target $11.90

Average Target $20.29

High Target $29.33

Current Price $0.15

Current
$0.15

Target
$20.29

$11.90 $20.29 avg $29.33

Scenario Analysis

Bear Case

$11.90

8,056.3%

Low target

Base Case

$20.29

+13,806.8%

Avg target

Bull Case

$29.33

+20,002.8%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$0.77

-81.0% from high

52-Week Low

$0.03

+386.3% from low

Target vs 52W High

$20.29

+2,548.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.0%
AMGN Amgen Inc	Hold	43	47%	$190.87	-52.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+150.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-13.2%
MRNA Moderna Inc	Hold	30	37%	$149.45	-21.3%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.6%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.2%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.8%